

Wall Street analysts changed ratings on top names. Check our analyst ratings page for full updates. THG, BFRI covered.
You can purchase shares of Biofrontera (NASDAQ:BFRI) through any online brokerage.
Other companies in Biofrontera’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Biofrontera has a consensus price target of $2.88.
The stock price for Biofrontera (NASDAQ: BFRI) is $0.8001 last updated October 30, 2026 at 6:50 PM EDT.
There are no upcoming dividends for Biofrontera.
Biofrontera does not have any upcoming earnings scheduled.
There is no upcoming split for Biofrontera.
Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which...